Eric G. Carter

529 total citations
11 papers, 420 citations indexed

About

Eric G. Carter is a scholar working on Gastroenterology, Surgery and Epidemiology. According to data from OpenAlex, Eric G. Carter has authored 11 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Gastroenterology, 6 papers in Surgery and 3 papers in Epidemiology. Recurrent topics in Eric G. Carter's work include Gastrointestinal motility and disorders (7 papers), Helicobacter pylori-related gastroenterology studies (5 papers) and Microscopic Colitis (3 papers). Eric G. Carter is often cited by papers focused on Gastrointestinal motility and disorders (7 papers), Helicobacter pylori-related gastroenterology studies (5 papers) and Microscopic Colitis (3 papers). Eric G. Carter collaborates with scholars based in United States and France. Eric G. Carter's co-authors include Vanessa Z. Ameen, Amy Heath, George E. Dukes, Emeran A. Mayer, Lin Chang, David McSorley, William Y. Chey, Allison R. Northcutt, William D. Chey and Susan Gordon and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Clinical Gastroenterology and Hepatology.

In The Last Decade

Eric G. Carter

10 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric G. Carter United States 7 363 161 141 100 49 11 420
A Feld United States 6 420 1.2× 211 1.3× 93 0.7× 70 0.7× 43 0.9× 7 494
James E. Mayle United States 6 363 1.0× 260 1.6× 127 0.9× 71 0.7× 29 0.6× 10 606
P. Rüegg Switzerland 4 653 1.8× 360 2.2× 210 1.5× 112 1.1× 35 0.7× 9 731
Ann E. Almazar United States 10 378 1.0× 222 1.4× 114 0.8× 39 0.4× 32 0.7× 19 438
William F. Norton United States 7 355 1.0× 142 0.9× 109 0.8× 88 0.9× 28 0.6× 10 452
Brigitte Nault Switzerland 5 726 2.0× 450 2.8× 197 1.4× 81 0.8× 40 0.8× 8 781
Carolina Bolino Canada 8 423 1.2× 218 1.4× 99 0.7× 56 0.6× 89 1.8× 12 499
Priya Oka United Kingdom 4 444 1.2× 146 0.9× 119 0.8× 69 0.7× 37 0.8× 4 544
Teodora Surdea‐Blaga Romania 11 314 0.9× 194 1.2× 81 0.6× 26 0.3× 42 0.9× 39 462
Alastair G. Bailey United Kingdom 8 456 1.3× 374 2.3× 68 0.5× 40 0.4× 42 0.9× 11 556

Countries citing papers authored by Eric G. Carter

Since Specialization
Citations

This map shows the geographic impact of Eric G. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric G. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric G. Carter more than expected).

Fields of papers citing papers by Eric G. Carter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric G. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric G. Carter. The network helps show where Eric G. Carter may publish in the future.

Co-authorship network of co-authors of Eric G. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Eric G. Carter. A scholar is included among the top collaborators of Eric G. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric G. Carter. Eric G. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Krause, Richard A., Vanessa Z. Ameen, Susan Gordon, et al.. (2007). A Randomized, Double-Blind, Placebo-Controlled Study to Assess Efficacy and Safety of 0.5 mg and 1 mg Alosetron in Women With Severe Diarrhea-predominant IBS. The American Journal of Gastroenterology. 102(8). 1709–1719. 96 indexed citations
2.
Ameen, Vanessa Z., et al.. (2006). Ranitidine (Zantac??) Syrup versus Ranitidine Effervescent Tablets (Zantac?? EFFERdose??) in Children. Pediatric Drugs. 8(4). 265–270. 22 indexed citations
3.
Ameen, Vanessa Z., et al.. (2006). Ranitidine (Zantac ® ) Syrup versus Ranitidine Effervescent Tablets (Zantac ® EFFERdose ® ) in Children Taste Preference Study. 2 indexed citations
4.
Chang, Lin, Vanessa Z. Ameen, George E. Dukes, et al.. (2005). A Dose-Ranging, Phase II Study of the Efficacy and Safety of Alosetron in Men with Diarrhea-Predominant IBS. The American Journal of Gastroenterology. 100(1). 115–123. 106 indexed citations
5.
Chey, William D., William Y. Chey, Amy Heath, et al.. (2004). Long-Term Safety and Efficacy of Alosetron in Women with Severe Diarrhea-Predominant Irritable Bowel Syndrome. The American Journal of Gastroenterology. 99(11). 2195–2203. 116 indexed citations
6.
Lembo, Anthony, et al.. (2004). Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: Analysis of two controlled trials. Clinical Gastroenterology and Hepatology. 2(8). 675–682. 56 indexed citations
7.
Ameen, Vanessa Z., Susan Gordon, Amy Heath, & Eric G. Carter. (2004). SYMPTOM SEVERITY IN WOMEN WITH DIARRHEA-PREDOMINANT IBS (D-IBS). The American Journal of Gastroenterology. 99. S275–S275. 1 indexed citations
8.
Northcutt, Allison R., et al.. (2004). MOST BOTHERSOME SYMPTOMS IN IRRITABLE BOWEL SYNDROME (IBS) PATIENTS. The American Journal of Gastroenterology. 99. S274–S275.
9.
Jhingran, Priti, et al.. (2001). Impact of differences in severity of irritable bowel syndrome (IBS) on patients' well being and resource use. Gastroenterology. 120(5). A406–A406. 6 indexed citations
10.
Olden, Kevin W., William D. Chey, John Boyle, Eric G. Carter, & Lin Chang. (2001). Health releated quality of life in irritable bowel syndrome: A community based study. Gastroenterology. 120(5). A634–A634. 4 indexed citations
11.
Harris, William T., et al.. (2001). Comorbid conditions in patients with irritable bowel syndrome: Data from A national IBS awareness registry. Gastroenterology. 120(5). A231–A231. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Feld Breakdown of academic impact, for papers by James E. Mayle Breakdown of academic impact, for papers by P. Rüegg Breakdown of academic impact, for papers by Ann E. Almazar Breakdown of academic impact, for papers by William F. Norton Breakdown of academic impact, for papers by Brigitte Nault Breakdown of academic impact, for papers by Carolina Bolino Breakdown of academic impact, for papers by Priya Oka Breakdown of academic impact, for papers by Teodora Surdea‐Blaga Breakdown of academic impact, for papers by Alastair G. Bailey
Rankless by CCL
2026